These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Short-term survival after major pulmonary resections for bronchogenic carcinoma. Hendriks J; Van Schil P; Van Meerbeeck J; Gdeedo A; Van Marck E; Vanmaele R; Eyskens E Acta Chir Belg; 1996; 96(6):273-9. PubMed ID: 9008769 [TBL] [Abstract][Full Text] [Related]
44. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma. Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B; Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590 [TBL] [Abstract][Full Text] [Related]
45. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy. Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925 [TBL] [Abstract][Full Text] [Related]
46. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter? Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924 [TBL] [Abstract][Full Text] [Related]
47. Results of superior vena cava resection for lung cancer. Analysis of prognostic factors. Spaggiari L; Magdeleinat P; Kondo H; Thomas P; Leon ME; Rollet G; Regnard JF; Tsuchiya R; Pastorino U Lung Cancer; 2004 Jun; 44(3):339-46. PubMed ID: 15140547 [TBL] [Abstract][Full Text] [Related]
48. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer? Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799 [TBL] [Abstract][Full Text] [Related]
50. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M; Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041 [TBL] [Abstract][Full Text] [Related]
51. [Place of bilobectomy in pulmonary oncology and prognostic factors in NSCLC]. Arame A; Rivera C; Pricopi C; Mordant P; Abdennadher M; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M Rev Pneumol Clin; 2014 Oct; 70(5):260-8. PubMed ID: 24932506 [TBL] [Abstract][Full Text] [Related]
52. [An analysis of 70 patients with bilobectomy for bronchogenic carcinoma]. Ayabe H; Tochiak H; Oka T; Hara S; Tagawa Y; Kawahara K; Tomita M Nihon Kyobu Geka Gakkai Zasshi; 1991 Aug; 39(8):1121-5. PubMed ID: 1658164 [TBL] [Abstract][Full Text] [Related]
53. Surgical treatment of non-small cell lung cancer in octogenarians. Fanucchi O; Ambrogi MC; Dini P; Lucchi M; Melfi F; Davini F; Mussi A Interact Cardiovasc Thorac Surg; 2011 May; 12(5):749-53. PubMed ID: 21297137 [TBL] [Abstract][Full Text] [Related]
54. Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes. Thomas PA; Falcoz PE; Bernard A; Le Pimpec-Barthes F; Jougon J; Brouchet L; Massard G; Dahan M; Loundou A; Eur J Cardiothorac Surg; 2016 Feb; 49(2):e38-43; discussion e43. PubMed ID: 27070154 [TBL] [Abstract][Full Text] [Related]
55. The risk of bilobectomy compared with lobectomy: a retrospective analysis of a series of matched cases and controls. Gómez MT; Jiménez MF; Aranda JL; Rodríguez M; Novoa NM; Varela G Eur J Cardiothorac Surg; 2014 Jul; 46(1):72-5. PubMed ID: 24242849 [TBL] [Abstract][Full Text] [Related]
56. Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients? Rivera C; Jougon J; Dahan M; Falcoz PE; Bernard A; Brouchet L Lung Cancer; 2012 May; 76(2):216-21. PubMed ID: 22078278 [TBL] [Abstract][Full Text] [Related]
57. Bilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer: A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life. Xie D; Deschamps C; Shen RK; Deng B; Wampfler JA; Cassivi SD; Nichols FC; Allen MS; Wigle DA; Yang P Ann Thorac Surg; 2015 Jul; 100(1):242-50. PubMed ID: 26007206 [TBL] [Abstract][Full Text] [Related]
58. 'Lung age' predicts post-operative complications and survival in lung cancer patients. Haruki T; Nakamura H; Taniguchi Y; Miwa K; Adachi Y; Fujioka S Respirology; 2010 Apr; 15(3):495-500. PubMed ID: 20210892 [TBL] [Abstract][Full Text] [Related]
59. Surgical treatment in patient with non-small-cell lung cancer with fissure involvement: anatomical versus nonanatomical resection. Leuzzi G; Cesario A; Cafarotti S; Lococo F; Dall'Armi V; Novellis P; Romano R; Siciliani A; Meacci E; Granone P; Margaritora S J Thorac Oncol; 2014 Jan; 9(1):97-108. PubMed ID: 24257140 [TBL] [Abstract][Full Text] [Related]
60. Should males ever undergo wedge resection for stage 1 non-small-cell lung cancer? A propensity analysis. Mediratta N; Shackcloth M; Page R; Woolley S; Asante-Siaw J; Poullis M Eur J Cardiothorac Surg; 2014 Aug; 46(2):267-73; discussion 273. PubMed ID: 24420371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]